Paralympic swimmer hopeful for return after corneal transplant | Analysis supports ovarian tissue transplant with BRCA mutations | NHS asks schools to teach about tissue, organ donation
September 13, 2017
AATB SmartBrief
News for the Tissue Banking Community
Top Story
Paralympic swimmer hopeful for return after corneal transplant
Stephanie Slater, 26, of Longridge, England, who won swimming medals at the 2016 Paralympics in Rio de Janeiro, said she has had a slow recovery following a corneal transplant in October. "It's been a tough year, but I'm ready and raring to go and can't wait for the new season," Slater said.
Lancashire Evening Post (U.K.) (9/13) 
LinkedIn Twitter Facebook Google+ Email
Tissue Banking in the News
Analysis supports ovarian tissue transplant with BRCA mutations
Ovarian tissue transplants can be used to preserve the fertility of breast cancer patients with BRCA mutations, according to a retrospective analysis presented at a meeting of the European Society for Medical Oncology. Oocyte density and the rate of oocyte retrieval were lower for women with BRCA mutations than those without, but the differences were not statistically significant.
Healio (free registration)/HemOnc Today (9/10) 
LinkedIn Twitter Facebook Google+ Email
NHS asks schools to teach about tissue, organ donation
Teachers in England are being urged by NHS Blood and Transplant to teach secondary students about tissue and organ donation and encourage them to discuss the topic with family and friends. "In order to help the thousands of people who are waiting now for a transplant, we need people to say yes to organ donation when faced with making the decision," NHSBT official Sally Johnson said.
Birmingham Mail (U.K.) (9/6) 
LinkedIn Twitter Facebook Google+ Email
Government & Regulatory
FDA grants orphan drug designation to Cellect Bio's ApoGraft
Cellect Biotechnology's ApoGraft therapy, a stem cell selection process that aims to lower the risk of acute and chronic graft-versus-host disease in patients undergoing transplants, was granted an orphan drug designation by the FDA. Data from Cellect's Phase I/II clinical trial could be available in the first quarter of 2018.
Seeking Alpha (free registration) (9/5) 
LinkedIn Twitter Facebook Google+ Email
New batch of biotech mosquitoes released in Brazil
A new batch of biotech mosquitoes was released in Brazil to fight diseases like Zika and chikungunya. The biotech mosquitoes contain the Wolbachia bacterium, which interferes with the mosquito's reproductive capacity.
Xinhua News Agency (China) (9/8) 
LinkedIn Twitter Facebook Google+ Email
Mosquito-borne diseases could surge as flooding recedes
Mosquito-borne diseases could surge as flooding recedes
(Luis Robayo/AFP/Getty Images)
Severe flooding in urban areas initially flushes out mosquito populations, but stagnant water that remains after floodwaters recede allow mosquito populations to explode, says epidemiologist and mosquito expert Chris Barker. West Nile virus is the primary concern in Houston, and Puerto Rico may see more mosquitoes carrying Zika and dengue viruses, Barker says.
Mother Jones online (9/7) 
LinkedIn Twitter Facebook Google+ Email
Grant funds development of 3D-printed implant to repair cartilage damage
The European Research Council has awarded a nearly $180,000 grant to a professor at Ireland's Trinity College to create a biodegradable 3D-printed implant that could help those with cartilage damage. "Our 3D-printed polymer posts will anchor the implant into the bone and will be porous to stimulate the migration of stem cells from the bone marrow into the body of the scaffold," said Daniel Kelly, the recipient of the grant.
3Ders (Netherlands) (9/5) 
LinkedIn Twitter Facebook Google+ Email
Zika virus targets glioblastoma cells in experiments
Researchers reported in The Journal of Experimental Medicine that they used Zika virus' affinity for brain cells to destroy glioblastoma stem cells. A modified strain of Zika virus inhibited brain tumor growth in mice, and a weak, naturally occurring strain of Zika virus also specifically went after and killed glioblastoma stem cells.
HealthDay News (9/5),  BBC (9/5) 
LinkedIn Twitter Facebook Google+ Email
Other News
Sponsorship opportunities available for AATB Annual Meeting
Please consider supporting the AATB Annual Meeting with a sponsorship. For details about available sponsorship opportunities, please contact Jamien Payne at
LinkedIn Twitter Facebook Google+ Email
Upcoming webinar!
Monday, Oct. 23: Post Mortem Changes: How Disease and Injuries Change From Onset to Assessment (2-3:30 p.m. EST). Speaker: Dr. Mark Giffen, University of New Mexico.
LinkedIn Twitter Facebook Google+ Email
Learn more about AATB:
About AATB | Professional Development
Standards and Regulatory | Membership
Competence, like truth, beauty and contact lenses, is in the eye of the beholder.
Laurence J. Peter,
educator and writer
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information